Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer

• Takeshi Azuma ,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: tazuma-tky@umin.ac.jp

  Affiliations Department of Urology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan, Department of Molecular Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Hongo, Tokyo, Japan, Department of Urology, The University of Tokyo Graduate School of Medicine, Hongo, Tokyo, Japan

  https://orcid.org/0000-0002-4921-2122

  ⨯
• Yujiro Sato,

  Roles Data curation, Funding acquisition

  Affiliation Department of Urology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan

  ⨯
• Tatsukuni Ohno,

  Roles Methodology, Supervision

  Affiliation Oral Health Science Center, Tokyo Dental College, Chiyoda, Tokyo, Japan

  ⨯
• Miyuki Azuma,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Molecular Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Hongo, Tokyo, Japan

  ⨯
• Haruki Kume

  Roles Supervision, Writing – review & editing

  Affiliation Department of Urology, The University of Tokyo Graduate School of Medicine, Hongo, Tokyo, Japan

  ⨯